Goldstein: Expect More Litigation After Myriad

June 13 (Bloomberg Law) -- Tom Goldstein, partner at Goldstein & Russell, PC and founder of SCOTUSblog, talks with Bloomberg Law's Lee Pacchia about the United States Supreme Court's decision in the Association for Molecular Pathology v. Myriad Genetics, Inc. case. At issue was whether patents may be granted on parts of the human body. He also explores whether Justice Scalia's concurrence raises doubts whether he believes in molecular biology, and where patent litigation will head in the wake of the decision. Bloomberg Law is a sponsor of SCOTUSblog.

Most Recent Videos

Bareburger CEO Responds to Shake Shack IPO
54:47 - Jan. 30 -- Bareburger CEO Euripides Pelekanos discusses how he will expand the Bareburger brand with Bloomberg's Pimm Fox on "Taking Stock."
  • How Apple Conquered China Market: Bloomberg West (01/30)
  • Should Amazon Spin Off Its Growing Cloud Business?
  • TripAdvisor's Top Pick: Chicago's Langham Hotel